PAPER Qadri YA, Ahmad K, Kim SW
SEARCH RESULTS
340304 RESULTS
PAPER Srivastava A, Renna HA, Johnson M, Sheehan K, Ahmed S, Palaia T, Pinkhasov A, Gomolin IH, Wisniewski T, De Leon J, Reiss AB
Nilotinib as a Prospective Treatment for Alzheimer's Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis.
Life (Basel). 2024 Sep 28;14(10) PubMed.PAPER Nakhal MM, Yassin LK, Alyaqoubi R, Saeed S, Alderei A, Alhammadi A, Alshehhi M, Almehairbi A, Al Houqani S, BaniYas S, Qanadilo H, Ali BR, Shehab S, Statsenko Y, Meribout S, Sadek B, Akour A, Hamad MI
The Microbiota-Gut-Brain Axis and Neurological Disorders: A Comprehensive Review.
Life (Basel). 2024 Sep 26;14(10) PubMed.PAPER Otani N, Kanda K, Ngatu NR, Murakami A, Yamadori Y, Hirao T
Association between Polypharmacy and Adverse Events in Patients with Alzheimer's Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER).
Medicina (Kaunas). 2024 Oct 6;60(10) PubMed.PAPER Gonçalves M, Costa M, Paiva-Martins F, Silva P
Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention.
Molecules. 2024 Oct 12;29(20) PubMed.PAPER Viveros-Paredes JM, González-Castañeda RE, Gertsch J, Chaparro-Huerta V, López-Roa RI, Vázquez-Valls E, Beas-Zarate C, Camins-Espuny A, Flores-Soto ME
Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60.
Pharmaceuticals (Basel). 2024 Oct 16;17(10) PubMed. Corrected paper.PAPER Al-Khayri JM, Ravindran M, Banadka A, Vandana CD, Priya K, Nagella P, Kukkemane K
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.
Pharmaceuticals (Basel). 2024 Oct 18;17(10) PubMed.PAPER Wohlfert AJ, Phares J, Granholm AC
The mTOR Pathway: A Common Link Between Alzheimer's Disease and Down Syndrome.
J Clin Med. 2024 Oct 17;13(20) PubMed.PAPER Huang L, Aronow WS
Association of Hypertension with Different Cognitive Disorders.
J Clin Med. 2024 Oct 10;13(20) PubMed.PAPER McGrath MS, Zhang R, Bracci PM, Azhir A, Forrest BD
Systemic Innate Immune System Restoration as a Therapeutic Approach for Neurodegenerative Disease: Effects of NP001 on Amyotrophic Lateral Sclerosis (ALS) Progression.
Biomedicines. 2024 Oct 16;12(10) PubMed.PAPER Kapsali I, Brinia ME, Constantinides VC
Cerebrospinal Fluid Total, Phosphorylated and Oligomeric A-Synuclein in Parkinson's Disease: A Systematic Review, Meta-Analysis and Meta-Regression Study.
Biomedicines. 2024 Oct 5;12(10) PubMed.PAPER Tolstova T, Dotsenko E, Luzgina N, Rusanov A
Preconditioning of Mesenchymal Stem Cells Enhances the Neuroprotective Effects of Their Conditioned Medium in an Alzheimer's Disease In Vitro Model.
Biomedicines. 2024 Oct 2;12(10) PubMed.PAPER Seta Y, Kimura K, Masahiro G, Tatsumori K, Murakami Y
SHED-CM: The Safety and Efficacy of Conditioned Media from Human Exfoliated Deciduous Teeth Stem Cells in Amyotrophic Lateral Sclerosis Treatment: A Retrospective Cohort Analysis.
Biomedicines. 2024 Sep 26;12(10) PubMed.PAPER Moriyama H, Yokota T
Recent Progress of Antisense Oligonucleotide Therapy for Superoxide-Dismutase-1-Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen.
Genes (Basel). 2024 Oct 20;15(10) PubMed.PAPER Popescu C, Munteanu C, Anghelescu A, Ciobanu V, Spînu A, Andone I, Mandu M, Bistriceanu R, Băilă M, Postoiu RL, Vlădulescu-Trandafir AI, Giuvara S, Malaelea AD, Onose G
Novelties on Neuroinflammation in Alzheimer's Disease-Focus on Gut and Oral Microbiota Involvement.
Int J Mol Sci. 2024 Oct 19;25(20) PubMed.Current Filters
No filters selected